Find Academic Supervisors

Zhe JiView profile

Assistant Professor

• Data Science
• Computational Biology
• Functional Genomics
• +4 more

Zhe Ji is an Assistant Professor in the Department of Biomedical Engineering at McCormick School of Engineering and the Department of Pharmacology at Feinberg School of Medicine, Northwestern University. His research integrates computational and experimental genomics to study gene transcription and RNA translation in cell fate commitment and oncogenic processes, aiming to develop precision medicine strategies. **Education**: Postdoctoral Fellow in Cancer Systems Biology, Harvard Medical School Postdoctoral Fellow in Computational Biology, Broad Institute of MIT and Harvard Ph.D. in Computational Genomics, Rutgers University B.S. in Biotechnology, Nanjing University, China **Research Focus**: Keywords include Data Science, Computational Biology, Functional Genomics, RNA, Cancer, Inflammation, and Machine Learning. The lab explores regulatory mechanisms underlying disease, with a focus on translational control, cancer metastasis, and inflammatory networks. **Grants & Advising**: No specific grants or student advisees listed. The lab emphasizes collaborative projects and computational-experimental approaches. **Lab Affiliations**: Zhe Ji’s lab is part of Northwestern’s interdisciplinary environment, bridging engineering and medicine to advance genomic technologies and therapeutic strategies.

Long CaiView profile

Professor

• Spatial Genomics
• Cellular Biology
• Developmental Biology
• +4 more

Long Cai is a Professor at the California Institute of Technology, affiliated with the Biology and Biological Engineering department. He pioneered the field of spatial genomics and co-developed transformative technologies such as seqFISH and MEMOIR. Research Interests: His work focuses on decoding biological systems through spatial genomics, integrating molecular imaging with computational analysis to uncover cellular organization in tissues. Key areas include developmental biology, neuroscience, kidney regeneration, and cancer biology. Publications: Recent studies highlight applications of spatial transcriptomics in kidney disease, brain nuclear architecture, and multi-omics tissue mapping. His research emphasizes creating high-resolution atlases of cellular dynamics. Scientific Awards: NIH Director’s Pioneer Award (2022) Labs & Collaborations: He leads the Cai Lab, which develops cutting-edge imaging tools in collaboration with the Elowitz Lab and other interdisciplinary teams.

• Stem Cell Biology
• Genetic Engineering
• Epigenetics
• +5 more

Konstantinos Anastassiadis is a Professor at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University of Technology , leading the Stem Cell Engineering group at the Biotechnology Center (BIOTEC) . His research focuses on unraveling molecular pathways regulating stem cell self-renewal and lineage commitment, with a strong emphasis on genetic engineering tool development and epigenetic mechanisms during cellular reprogramming. The lab utilizes mouse and human embryonic stem cells, neural stem cells, mesenchymal stromal cells, and induced pluripotent stem cells (iPSCs) in their investigations. Core Research Areas: Molecular regulation of stem cell fate Epigenetic mechanisms (e.g., UTX/UTY histone demethylases) Genetic engineering tool development (Flp, Dre, Vika recombinases, CRISPR protocols) Conditional immortalization systems for rare cell expansion Publications highlight his contributions to understanding: Role of histone methyltransferases (MLL1, MLL2, Setd1b) in hematopoiesis and cancer Epigenetic regulation during mouse development and spermatogenesis Genetic tools for protein tagging, transposon-mediated BAC transgenesis Interactions between stem cells and niche microenvironments Transcriptional and mechanical markers during reprogramming Collaborations span immunology , developmental biology , and bioinformatics . The lab actively participates in teaching activities at CMCB and maintains a focus on translational applications of stem cell research.

Omer BayraktarView profile

Researcher

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +3 more

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

• Neuroscience
• Synaptic Plasticity
• Neural Circuit Formation
• +4 more

Colin J Akerman is Professor of Neuroscience and Group Leader in the Department of Pharmacology at the University of Oxford, concurrently serving as Corange Fellow and Medical Tutor at Corpus Christi College. His research investigates fundamental mechanisms of synaptic circuit formation and plasticity, with direct implications for epilepsy, dementia, and schizophrenia through multidisciplinary approaches integrating electrophysiology, optical imaging, and computational modeling. His primary research interests encompass Synaptic Plasticity, Neural Circuit Formation, and Excitatory-Inhibitory Balance, with specific focus on neuronal progenitor influences on connectivity, chloride dynamics in inhibitory transmission, and learning mechanisms in disease contexts. The lab employs custom-built equipment and molecular tools to probe synaptic function across in vivo , in vitro , and in silico platforms, emphasizing how activity-dependent processes shape neural networks during development and disease. Recent publications (2023-2025) reveal strong thematic convergence on intracellular chloride regulation in sleep-wake cycles, cortical circuit assembly from embryonic progenitors, and innovative optical tools for neural monitoring. This work bridges molecular neuroscience with systems-level understanding of synaptic plasticity, particularly regarding ionic mechanisms in epilepsy and sleep homeostasis. No scientific awards or fellowships are explicitly documented in the source materials. Professor Akerman currently mentors four PhD students (Vourvoukelis, Selfe, Wang, Gemayel) and multiple postdoctoral researchers, having previously trained scientists now leading independent groups in Toronto, Edinburgh, Cape Town, Oxford, and London. His research is funded by the European Research Council, Innovative Medicines Initiative, and Wellcome Trust, supporting investigations into synaptic mechanisms underlying neurological disorders. The Akerman Group, established in 2008, operates as an integrative neuroscience hub within Oxford's Pharmacology Department. The 10-member team combines expertise in patch-clamp electrophysiology, optogenetics, multiphoton imaging, and computational modeling, with current projects spanning neuronal progenitor biology, inhibitory synaptic plasticity, and learning rule implementation in neural networks. The lab emphasizes technical innovation, regularly developing custom instrumentation and molecular tools for neural observation and manipulation.

• Cancer Biology
• Mathematical and Computational Modeling
• Bioinformatics
• +7 more

Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.

Yukiko GotohView profile

Professor

• Neural Development
• Neural Stem/Progenitor Cells
• Epigenetics
• +7 more

Yukiko Gotoh is a Professor at the Department of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo. She serves as the Deputy Director and Principal Investigator at the International Research Center for Neurointelligence (IRCN). Her research focuses on understanding the mechanisms that regulate neural stem/progenitor cell fate during embryonic brain development and in the adult brain. Dr. Gotoh's research interests include: Genetic and epigenetic regulation of neural stem/progenitor cell fate Neuronal maturation processes Genesis and maintenance of adult neural stem cells Relevance of neural stem/progenitor cell dysregulation in neurodevelopmental disorders such as autism spectrum disorders Investigation of mechanisms regulating neural stem-progenitor cell fate during neocortical development Genetic and epigenetic regulation of neuronal activation Analysis of Dr. Gotoh's recent publications reveals a strong focus on neural stem cell biology, epigenetic regulation, and neurodevelopmental disorders. Her work demonstrates how chromatin modifiers like Polycomb group proteins and HMGA proteins regulate neural stem cell fate decisions during brain development. A significant portion of her research explores the embryonic origins of adult neural stem cells and how dysregulation of these processes contributes to conditions like autism spectrum disorders and schizophrenia. Her laboratory also investigates the basic mechanisms of cellular responses to viral infection in the brain and their relevance to neurodevelopmental disorders. Dr. Gotoh has made significant contributions to understanding: The role of Polycomb group proteins in neural development How chromatin modifiers regulate neurogenic potential Cell cycle regulation in neural stem cells The PDK1-Akt pathway in neuronal migration Layer-specific heterogeneity of astrocytes Mechanisms underlying schizophrenia-related abnormalities Dr. Gotoh's laboratory conducts research on multiple fronts related to neural development and stem cell biology. Her team investigates: Mechanisms regulating neural stem-progenitor cell fate during neocortical development Genetic and epigenetic regulation of neuronal activation The embryonic origin of adult neural stem cells Dysregulation of neural stem-progenitor cell and neuronal fate in neurodevelopmental disorders Innate immune responses in the brain

Jianping FuView profile

Professor

• Stem Cell Bioengineering
• Developmental Bioengineering
• Mechanobiology
• +4 more

Jianping Fu is a Professor in the Department of Mechanical Engineering at the University of Michigan , with joint appointments in Biomedical Engineering and Cell and Developmental Biology. His research integrates micro/nanoengineering , mechanobiology , and stem cell biology to model human development and disease. Education: PhD (MIT, 2007), BE (University of Science and Technology of China, 2000) His research interests focus on stem cell bioengineering , developmental bioengineering , and mechanobiology , particularly in modeling early post-implantation human development, neural tube formation, and pluripotent stem cell mechanoregulation. His work combines biomimetic culture systems with microfluidic gradients to study embryogenesis and organogenesis. Recent publications highlight advances in human embryo modeling (2024 Cell, Nature, Cell Stem Cell), neural tube patterning (2024 Nature), and mechanobiology of stem cells (2024 Nature Reviews Physics). These studies emphasize computational methods , single-cell analysis , and standardization of embryo models . Scientific honors include: Friedrich Wilhelm Bessel Research Award (2022) ISSCR Merit Award (2024) Fellow, American Institute for Medical and Biological Engineering (2019) NSF CAREER Award (2012) Life Member, World Association of Chinese Biomedical Engineers (2024) Dr. Fu mentors extensively, with 20+ alumni including PhD students and postdocs now in academic and industry positions. His lab has received $3M NIH funding for immunological diagnostics and MTRAC grants for translational research. Collaborations with institutions like Cincinnati Children's Hospital and Rice University enhance his interdisciplinary approach to regenerative medicine.

Jun WuView profile

Assistant Professor

• Stem Cell Biology
• Genome Editing
• Interspecies Chimeras
• +6 more

Dr. Jun Wu is an Assistant Professor in the Department of Molecular Biology at UT Southwestern Medical Center. He holds a PhD in Life Science from the University of Tennessee and completed postdoctoral training at the University of Southern California and the Salk Institute. His research focuses on stem cell biology, genome editing, and interspecies chimeras to advance regenerative medicine and developmental biology. Education: Bachelor of Medicine, Shandong University School of Medicine (China) PhD in Life Science, University of Tennessee (2013) Postdoctoral Fellowships: USC (2013-2015) and Salk Institute (2015-2017) Research Interests: Generation of pluripotent stem cells with distinct molecular/phenotypic features Development of interspecies blastocyst complementation systems Modeling peri-implantation human development using stem cell embryo models Study of species-specific developmental barriers and evolutionary biology Application of chimeras to study cancer resistance and organ size determination Lab Activities: The Wu Lab develops stem cell models to study mammalian development and create regenerative therapies. Key projects include: Creation of interspecies chimeras (human-monkey, rat-mouse) Development of blastoids and peri-gastruloids Analysis of species-specific cell competition mechanisms Engineering cross-species organogenesis systems Grant Activities: Focuses on NIH-funded projects related to stem cell biology, interspecies chimerism, and regenerative medicine applications. Collaborates with institutions like Salk Institute and University of California campuses. Lab Team: Includes postdoctoral researchers like Dr. Yi Ding and a multidisciplinary team of molecular biologists, bioengineers, and computational biologists.

• Neuroscience
• Developmental Biology
• Molecular Biology
• +3 more

Carina Hanashima is a Professor at the Faculty of Education and Integrated Arts and Sciences , Waseda University, Japan. Her research focuses on neuroscience , developmental biology , and molecular mechanisms underlying cortical development . She has held academic positions at Kobe University (2014.04-2018.03), RIKEN (2008.10-2017.03), Osaka University (2012.04-2015.03), and Nara Women's University (2007.09-2014.11). Research Interests Neuronal specification and cortical circuit formation Role of transcription factors (e.g., Foxg1, Robo1) in brain development Gene regulatory networks in neurogenesis Evolutionary origins of the neocortex Recent Trends in Publications : Her work explores transcriptional repression , axon guidance signaling , and developmental clock mechanisms in mammalian and non-mammalian models (chicks, mice). Key themes include neurodevelopmental disorders (e.g., autism, schizophrenia), angiogenesis , and cell migration . Scientific Awards : Poster Award, Asia-Pacific Developmental Biology Conference APDBC (2012.10) Grants and Projects : Japan Society for the Promotion of Science Grants-in-Aid (2016.06-2021.03, 2021.04-2022.03) RIKEN Joint Retreat Organizer (2011-2017) Labs and Collaborations : She leads the Hanashima Lab at Waseda University, focusing on spatiotemporal control in neuronal identity and neurovascular coupling . Her lab employs genetic lineage tracing , in situ hybridization , and in utero electroporation techniques.

Kei ItoView profile

Professor

• Neuroscience
• Drosophila Brain Architecture
• Glial Cell Biology
• +4 more

Prof. Dr. Kei Ito is a leading neuroscientist at the University of Cologne , specializing in Drosophila melanogaster brain architecture. His research focuses on mapping " terra incognita " regions of the brain, analyzing glial cell functions across development, and establishing standardized insect brain nomenclature through international collaboration. As AXA Chairholder and former HHMI Senior Fellow , he combines molecular genetics with 3D virtual reality visualization to unravel neuronal network organization . Academic Affiliation : University of Cologne (2016–present) Prior Positions : The University of Tokyo (2002–2017), National Institute for Basic Biology (1998–2002) Research Interests span multiple domains: "Terra Incognita" Analysis : Systematic mapping of previously uncharacterized brain regions (70% of brain volume) Glial Cell Biology : Classification and functional analysis from embryo to adult Connectome Research : Integration of electron microscopy data with genetic tools Neuronal Lineage Studies : 3D reconstruction of neuroblast progeny patterns Scientific Contributions include: Creation of 4,500 NP Gal4 driver lines (Japan consortium, 1998) Pioneering Split-Gal4 systems for precise neuron labeling Establishment of 6 distinct neuron naming schemes for EM data Leadership in Insect Brain Name Working Group (2007–2014) Advising Legacy features direct mentorship of 6 doctoral students and collaborative analysis of 3,777 neuron types in EM datasets. His lab maintains 1,000+ specific Split-Gal4 lines for terra incognita research.

Alessandra MorettiView profile

Professor

• Stem Cell Biology
• Cardiovascular Development
• Cardiovascular Progenitor Cells
• +4 more

Prof. Alessandra Moretti is a Professor of Regenerative Medicine of Cardiovascular Diseases at the Technical University of Munich (TUM), School of Medicine and Health. She leads research in stem cell biology and cardiovascular development, with a focus on regenerative therapeutic approaches for heart diseases. Her educational background includes a degree in Chemistry and Pharmacy from the University of Padua, Italy, where she earned her doctorate in 1997. She completed four years of postdoctoral research at the University of California, San Diego, and Harvard Medical School's Massachusetts General Hospital. Prof. Moretti's research centers on cardiovascular progenitor cells, cellular plasticity, and human induced pluripotent stem cells for modeling cardiovascular diseases. Her work bridges fundamental developmental biology and clinical applications, targeting cardiac cell specification mechanisms and novel treatments for heart failure and muscular dystrophies through regenerative approaches. Her publication trajectory shows progression from foundational discoveries in cardiac progenitor cells (e.g., Isl1+ lineage studies) to translational applications like gene editing for Duchenne muscular dystrophy. The research consistently integrates molecular mechanisms of cardiomyocyte identity with disease modeling using patient-specific stem cells. She has received several prestigious awards, including: ERC Advanced Grant (2018) German University Medicine Innovation Award (2013) Biology Prize of the Göttingen Academy of Sciences (2012) Principal Investigator of the German Center for Cardiovascular Research (DZHK) (since 2011) Astra-Zeneca Prize for Cardiovascular Research (2006) Prof. Moretti leads a research group at Klinikum rechts der Isar focusing on stem cell-based cardiovascular regeneration. Her laboratory investigates molecular pathways in heart development and disease using advanced stem cell models, supported by major grants including the ERC Advanced Grant and DZHK funding. She continues to advance therapeutic strategies for cardiac repair through gene editing and stem cell engineering.

• Zebrafish Research
• Vascular Biology
• Lymphatic Development
• +3 more

Dr. Kazuhide Shaun Okuda is a Senior Lecturer and Group Leader at the La Trobe Institute for Molecular Science, Department of Biochemistry and Chemistry at La Trobe University, Australia. He also holds honorary positions at Peter MacCallum Cancer Centre and the University of Melbourne. With extensive experience in zebrafish research and vascular biology, Dr. Okuda has established himself as an expert in lymphatic development, disease modeling, and drug discovery. Dr. Okuda earned his PhD in Molecular Medicine from the University of Auckland, New Zealand (2010-2014), where he generated groundbreaking zebrafish transgenic lines for lymphatic vessel imaging. His subsequent postdoctoral work at Cancer Research Malaysia and the University of Queensland/Peter MacCallum Cancer Centre focused on anti-cancer therapeutics screening and dynamic signaling events during development and regeneration. His research focuses on understanding lymphoedema mechanisms, identifying therapies that modulate vascular growth, and elucidating dynamic mechanisms of vascular development and disease progression. Dr. Okuda's work has significant potential impact in developing new treatments for lymphoedema and diseases with excessive vascular growth such as cancer and lymphatic malformations. Analysis of Dr. Okuda's publication record shows a consistent focus on vascular and lymphatic development using zebrafish models. His most recent work (2023-2025) demonstrates an expansion into drug delivery systems, advanced imaging techniques, and single-cell analysis approaches while maintaining his core interest in lymphangiogenesis mechanisms and therapeutic interventions. Dr. Okuda has received significant research funding, including a National Health and Medical Research Council Ideas Grant (2024-2027) for his project on 'Cellular signalling and growth control in vascular development and lymphatic malformations.' Primary supervisor of PhD students (X4), La Trobe University (2023-present) Co-supervisor of PhD students (X3), University of Melbourne (2020-present) Co-supervisor of a PhD student, La Trobe University (2023-present) Senior Lecturer and Group Leader, La Trobe Institute for Molecular Science (2023-present) Honorary Scientist, Peter MacCallum Cancer Centre (2023-present) Honorary Fellow, University of Melbourne (2020-present) Dr. Okuda leads a research group at the La Trobe Institute for Molecular Science focused on identifying therapeutic leads/targets that modulate the vasculature and studying dynamic signaling mechanisms in endothelial cells using zebrafish models. His team has made significant contributions to understanding lymphatic development, including the identification of Ddx21 and ribosome biogenesis as novel regulators of embryonic lymphangiogenesis.

• Neuroscience
• Olfactory System
• Central Nervous System Development
• +4 more

Charles A. Greer is Professor of Neurosurgery and Neuroscience at Yale School of Medicine, where he serves as Co-Vice Chair of Research for Neurosurgery and Director of the Yale Interdepartmental Neuroscience Graduate Program. He maintains joint appointments in both the Department of Neurosurgery and Department of Neuroscience, with additional affiliations through the Wu Tsai Institute, Yale Combined Program in the Biological and Biomedical Sciences, and Yale Stem Cell Center. Dr. Greer's research focuses on understanding the fundamental mechanisms that establish orderly topographic maps within the central nervous system during development and regeneration. His laboratory primarily investigates the complex olfactory system, studying how axons sort into functional subsets and target specific regions in the olfactory bulb. His work has significant implications for understanding neural regeneration following injury or disease, particularly through his research on ensheathing cells that support axon growth and can promote remyelination in damaged spinal cord tissue. His research spans multiple disciplines including neuroanatomy, developmental neuroscience, and neural regeneration, with particular emphasis on the molecular and cellular mechanisms of axon targeting, glial cell function, and neural circuit formation. Dr. Greer has established extensive collaborations across Yale departments including Neurology, Neurobiology, Anesthesiology, and Ophthalmology, as well as with institutions including Columbia University, Emory University, The Rockefeller University, University of Maryland, and University of Colorado. Dr. Greer has received numerous prestigious awards including the Max Mozell Award for Outstanding Achievements in the Chemical Senses, the R.H. Wright Award for Outstanding Research in Olfaction, and recognition as Distinguished Professor from Universite Pierre et Marie Curie in Paris. He has served as President of the Association for Chemoreception Sciences and as a member of NIH study sections and the Advisory Council for the National Institute on Deafness and Other Communication Disorders. As an educator, Dr. Greer has directed the Yale Interdepartmental Neuroscience Graduate Program and mentored numerous students and postdoctoral fellows. He serves as Associate Editor for The Journal of Comparative Neurology and Journal of Neuroscience, and sits on the editorial boards of several other neuroscience journals. His extensive publication record demonstrates sustained contributions to understanding the organization and development of neural systems, particularly the olfactory pathway.

Pengyi YangView profile

Associate Professor

• Computational Systems Biology
• Stem Cell Biology
• Bioinformatics
• +4 more

Pengyi Yang is an Associate Professor and University of Sydney Robinson Fellow at the School of Mathematics & Statistics, University of Sydney. He leads the Computational Systems Biology group at the Charles Perkins Centre and holds a conjoint appointment as Unit Head of Computational Systems Biology at the Children's Medical Research Institute (CMRI). His research focuses on computational approaches to understand trans-regulatory networks in stem cells and their applications in regenerative medicine. Yang holds a Ph.D. and has been recognized with awards such as the National Stem Cell Foundation Metcalf Prize (2021). His research spans computational systems biology, machine learning for bioinformatics, and spatial/single-cell omics analysis. Key projects include modeling pluripotency transitions, developing stem cell-derived organoids, and creating computational tools for phosphoproteomics and multi-omics integration. Collaborations include international initiatives like the Laboratory of Data Discovery for Health (InnoHK). Yang advises multiple PhD students and leads grants on topics like stem cell-derived brain organoids and embryonic development modeling. His lab develops tools like Cepo, PhosR, and CiteFuse for omics data analysis. He teaches data science and molecular systems biology at the University of Sydney.